Takeda Oncology invites you to participate in this ASH 2024: Lymphoma and Multiple Myeloma Highlights meeting. C-ANPROM/GB/OG/0761 November 2024

TOPICS COVERED

The Takeda Oncology Medical team invites healthcare professionals from the UK and Ireland working in haemato-oncology to the non-promotional, scientific exchange ASH 2024 Lymphoma and Multiple Myeloma Highlights meeting. The meeting takes place on Wednesday 15 January 2025, 17:55–21:10 and will be Chaired by Dr Wendy Osborne.

At the meeting, an expert panel of speakers will present their selected abstracts from ASH 2024 which will be followed by an interactive discussion where attendees will have the opportunity to ask questions and debate with speakers. Interaction with the Faculty is strongly encouraged. Topics will include: multiple myeloma, Hodgkin lymphoma, and high- and low-grade lymphoma.

C-ANPROM/GB/OG/0761  November 2024

WHO SHOULD ATTEND?

Healthcare professionals who specialise in haemato-oncology

C-ANPROM/GB/OG/0761  November 2024

SPEAKERS

• Dr Wendy Osborne (Chair), Freeman Hospital, Newcastle upon Tyne
• Dr Cathy Burton, St James’s University Hospital, Leeds
• Dr Tobias Menne, Freeman Hospital, Newcastle upon Tyne
• Dr Helen Marr, Freeman Hospital, Newcastle upon Tyne
• Professor Graham Collins, Churchill Hospital, Oxford
• Dr Karthik Ramasamy, Churchill Hospital, Oxford

This non-promotional, scientific exchange meeting is organised and fully funded by the medical department of Takeda UK Ltd and is intended for healthcare professionals from the UK and Ireland with a clinical speciality in haemato-oncology only. This meeting may include discussion of both investigational and licensed agents and is in no way intended to promote Takeda products.

C-ANPROM/GB/OG/0761  November 2024

For more information, please contact: [email protected].